Drug Profile
Herpes simplex DNA vaccine - Admedus Immunotherapies
Alternative Names: Herpes vaccine - Allied Healthcare Group; HSV-2 vaccine - Admedus Immunotherapies; HSV-2 vaccine - Allied Healthcare GroupLatest Information Update: 16 Feb 2018
Price :
$50
*
At a glance
- Originator University of Queensland
- Developer Admedus Immunotherapies
- Class DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Herpes simplex virus infections